Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00779155 · ClinicalTrials.gov registry record · Phase 2

Study of Magnetic Fields for Treatment of Parkinson's Disease

A Phase 2 study of Parkinson's Disease, sponsored by pico-tesla Magnetic Therapies.

Completed
Registry status
Phase 2
Development phase
12
Enrollment target
1
Study location

NCT00779155 is a Phase 2 study of Parkinson's Disease that has completed, run by pico-tesla Magnetic Therapies. The registered enrollment target is 12 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00779155, a Phase 2 study of Parkinson's Disease, has completed, sponsored by pico-tesla Magnetic Therapies.

COMPLETED
Registry status
Phase 2
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if low level magnetic fields may help to relieve symptoms of Parkinson's disease.

Conditions Studied

Parkinson's Disease

Interventions

  • DEVICE The Resonator
  • DEVICE The Resonator control

Study Locations (1)

Colorado

  • pico-tesla Magnetic Therapies - Littleton

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2007-08
Est. Completion 2009-06
Phase Phase 2

Sponsor

pico-tesla Magnetic Therapies

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00779155

The ClinicalTrials.gov registry entry for NCT00779155 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (98% lower). The listed sponsor is pico-tesla Magnetic Therapies, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 2 interventions - of which The Resonator is the first listed.

NCT00779155 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT00779155 about?

NCT00779155 is a clinical study titled "Study of Magnetic Fields for Treatment of Parkinson's Disease". The purpose of this study is to determine if low level magnetic fields may help to relieve symptoms of Parkinson's disease.

What is the current status of trial NCT00779155?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2007-08. Estimated completion is 2009-06.

What conditions does trial NCT00779155 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT00779155?

The interventions under investigation include: The Resonator (DEVICE), The Resonator control (DEVICE).

Who is sponsoring clinical trial NCT00779155?

This trial is sponsored by pico-tesla Magnetic Therapies, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00779155 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson's Disease

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.